A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis

Abstract

Non-adherence to anti-tubercular therapy Mycobacterium tuberculosis infection can lead to treatment failure and even the development of drug resistance. In this work, the authors develop a long-acting delivery system of the anti-tuberculosis drug rifabutin and assess translational potential in vivo.